[National Disease Management Guideline Type 2 Diabetes. Part 1: Pharmacotherapy of glucose metabolism plus shared decision making and participation in all relevant areas of life]
MMW Fortschr Med
.
2021 Apr;163(8):42-47.
doi: 10.1007/s15006-021-9814-x.
[Article in German]
Authors
Rüdiger Landgraf
1
,
Jens Aberle
2
,
Bernhard Kulzer
3
Affiliations
1
Deutsche Diabetes Stiftung (DDS), Düsseldorf, Germeringerstrasse 10 ½, 82131, Gauting, Deutschland. ruediger.landgraf@gmx.de.
2
Sektion Endokrinologie und Diabetologie, Universitäres Adipositas-Zentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
3
Forschungsinstitut der Diabetes Akademie (FIDAM), Diabetes-Zentrum Bad Mergentheim, Bad Mergentheim, Deutschland.
PMID:
33904092
DOI:
10.1007/s15006-021-9814-x
No abstract available
Publication types
Review
MeSH terms
Decision Making
Decision Making, Shared*
Diabetes Mellitus, Type 2* / drug therapy
Disease Management
Glucose
Humans
Patient Participation
Substances
Glucose